A scientific response to Moritz et al. (2022).

Published in: Psychotherapy (Chicago, Ill.) (2022)

This brief response addresses questions and concerns raised by Moritz and colleagues regarding our Burlingame et al.'s (2020) meta-analysis of group protocols effectiveness with patients diagnosed with schizophrenia (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
randomized controlled trial
systematic review
bipolar disorder
peritoneal dialysis
prognostic factors
patient reported outcomes
adverse drug
electronic health record